http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4045176-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2727eec48ec00399c9121c11086b7df4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f6560b7c93673bfeb1356f7888aabc8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-105831
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-106664
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-107497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-109163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2496-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-104165
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-96
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-96
filingDate 1976-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1977-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3141246cecd543e1927b396f92a5404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_869086cf8273859e294c4d396d1be625
publicationDate 1977-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4045176-A
titleOfInvention Preparation of optically clear serum
abstract A stable optically clear serum is prepared for use in the preparation of standards and quality control reference material for the assay of human serum components. In one aspect of the present invention, high density lipoproteins isolated from human blood serum are added to substantially human serum to produce a standard or reference material. A second aspect of the present invention involves the addition of isolated, non-primate lipoproteins to substantially human serum. The serum prepared as disclosed has good optical clarity upon lyophilization and reconstitution with aqueous media. Alternatively, the isolated lipoproteins are added in an aqueous diluent to lyophilized human serum.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6440747-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11634257-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11747082-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4188188-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0140495-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4438202-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4743682-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4103685-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4211530-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004014942-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4216117-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4908354-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-7900306-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11604026-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0048209-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5460974-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4465774-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11609042-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11609043-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8303680-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4226713-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4110077-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5770451-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4210557-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103472240-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0105923-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0105923-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4632907-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103472240-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4668772-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5614414-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0022128-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0006822-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11740019-B2
priorityDate 1975-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3682835-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3274062-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3764556-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3955925-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3260648-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47851
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9PS30
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121089
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31886
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24393
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Y4Z0
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07492
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ863C3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11025495
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63152
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8R1I2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63153
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01295

Total number of triples: 86.